CLSI M52 (R2020) – Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E
This guideline includes recommendations for verification of commercial US Food and Drug Administration?cleared microbial identification and antimicrobial susceptibility testing systems by clinical laboratory professionals to fulfill regulatory or quality assurance requirements for the use of these systems for diagnostic testing.
